<?xml version='1.0' encoding='utf-8'?>
<document id="25336752"><sentence text="The hepatobiliary disposition of timosaponin b2 is highly dependent on influx/efflux transporters but not metabolism."><entity charOffset="33-47" id="DDI-PubMed.25336752.s1.e0" text="timosaponin b2" /></sentence><sentence text="The purpose of this study was to characterize the hepatobiliary disposition of timosaponin B2 (TB-2), a natural saponin"><entity charOffset="79-93" id="DDI-PubMed.25336752.s2.e0" text="timosaponin B2" /><entity charOffset="112-119" id="DDI-PubMed.25336752.s2.e1" text="saponin" /><pair ddi="false" e1="DDI-PubMed.25336752.s2.e0" e2="DDI-PubMed.25336752.s2.e0" /><pair ddi="false" e1="DDI-PubMed.25336752.s2.e0" e2="DDI-PubMed.25336752.s2.e1" /></sentence><sentence text=" Although TB-2 has multiple pharmacologic activities, the mechanism of its hepatobiliary disposition has not been explored" /><sentence text=" Because the metabolism of TB-2 is limited and the accumulation of TB-2 in primary hepatocytes is highly temperature dependent (93% of its accumulation is due to active uptake), the contribution of hepatic transporters was investigated" /><sentence text=" Organic anion-transporting polypeptide (OATP) 1B1- and OATP1B3-transfected human embryonic kidney 293 cells were employed" /><sentence text=" TB-2 serves as a substrate for OATP1B1 and OATP1B3, with the former playing a predominant role in the hepatic uptake of TB-2" /><sentence text=" An inhibition study in sandwich-cultured rat hepatocytes suggested that TB-2 is a substrate for both breast cancer resistance protein (Bcrp) and multidrug resistance-associated protein 2 (Mrp2), consistent with its high biliary excretion index (43" /><sentence text="1-44" /><sentence text="9%)" /><sentence text=" This hypothesis was further verified in BCRP and MRP2 membrane vesicles" /><sentence text=" The cooperation of uptake and efflux transporters in TB-2 hepatic disposition could partially explain the double-peak phenomenon observed in rat plasma and liver and biliary clearance, which accounted for 70% of the total TB-2 clearance" /><sentence text=" Moreover, TB-2 significantly increased the rosuvastatin concentration in rat plasma in a concentration-dependent manner and decreased its biliary excretion, which corresponded to reductions in rosuvastatin accumulation in hepatocytes and the biliary excretion index in sandwich-cultured rat hepatocytes, representing a perfect example of a potential saponin-statin drug-drug interaction"><entity charOffset="44-56" id="DDI-PubMed.25336752.s12.e0" text="rosuvastatin" /><entity charOffset="194-206" id="DDI-PubMed.25336752.s12.e1" text="rosuvastatin" /><entity charOffset="351-358" id="DDI-PubMed.25336752.s12.e2" text="saponin" /><pair ddi="false" e1="DDI-PubMed.25336752.s12.e0" e2="DDI-PubMed.25336752.s12.e0" /><pair ddi="false" e1="DDI-PubMed.25336752.s12.e0" e2="DDI-PubMed.25336752.s12.e1" /><pair ddi="false" e1="DDI-PubMed.25336752.s12.e0" e2="DDI-PubMed.25336752.s12.e2" /><pair ddi="false" e1="DDI-PubMed.25336752.s12.e1" e2="DDI-PubMed.25336752.s12.e1" /><pair ddi="false" e1="DDI-PubMed.25336752.s12.e1" e2="DDI-PubMed.25336752.s12.e2" /></sentence><sentence text=" These studies demonstrate that transporters (Oatp, Bcrp/Mrp2), but not metabolism, contribute significantly to rat TB-2 hepatobiliary disposition" /><sentence text=" " /></document>